Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae : in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin.

Authors :: Boattini M
Bianco G
Iannaccone M
Bondi A
Cavallo R
Costa C
Source :: Journal of chemotherapy (Florence, Italy) [J Chemother] 2021 Dec; Vol. 33 (8), pp. 598-600. Date of Electronic Publication: 2021 Apr 10.
Publication Year :: 2021

Subjects :: Anti-Bacterial Agents administration & dosage
Azabicyclo Compounds pharmacology
Boronic Acids administration & dosage
Ceftazidime pharmacology
Drug Combinations
Drug Resistance, Multiple, Bacterial genetics
Fosfomycin administration & dosage
Genes, Bacterial
Genotype
Heterocyclic Compounds, 1-Ring administration & dosage
Meropenem administration & dosage
Anti-Bacterial Agents pharmacology
Boronic Acids pharmacology
Fosfomycin pharmacology
Heterocyclic Compounds, 1-Ring pharmacology
Klebsiella pneumoniae drug effects
Meropenem pharmacology

Full Text Access

Tools